← All Novavax INC filings

Novavax INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
NVAX
Novavax INC
SCHEDULE: State Street Corp. Discloses Novavax Stake
State Street Corporation has updated its Schedule 13G filing to reflect beneficial ownership of 7.1% of Novavax Inc. common stock as of June 30, 2026.
NASDAQ
NVAX
Novavax INC
SCHEDULE: Vanguard Discloses 5.09% Stake in Novavax
Vanguard Capital Management has reported beneficial ownership of over 8.3 million shares, representing 5.09% of Novavax Inc.'s common stock.
NASDAQ
NVAX
Novavax INC
SCHEDULE: Bank of America Discloses 4.1% Stake in Novavax
Bank of America Corporation has reported a 4.1% beneficial ownership in Novavax Inc. common stock as of March 31, 2026.
NASDAQ
NVAX
Novavax INC
SCHEDULE: Vanguard Group Reports 0% Novavax Beneficial Ownership
The Vanguard Group has reported a 0% beneficial ownership in Novavax Inc. common stock following an internal realignment.
NASDAQ
NVAX
Novavax INC
SCHEDULE: Bank of America Discloses 5.1% Stake in Novavax
Bank of America Corporation and its subsidiaries have reported a 5.1% beneficial ownership stake in Novavax Inc. common stock.
NASDAQ
NVAX
Novavax INC
SCHEDULE: State Street Discloses 5.9% Stake in Novavax
State Street Corporation has reported a 5.9% beneficial ownership stake in Novavax Inc., holding over 9.5 million shares of common stock.
NASDAQ
NVAX
Novavax INC
SCHEDULE 13G/A: BlackRock Amends SEC Filing, Disclosing 8.4% Stake in Novavax Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.4% of Novavax Inc.'s common stock as of December 31, 2024.